Application of these techniques to the circadian regulatory network in Arabidopsis has uncovered a number of discrepancies within established models as well as novel regulatory interactions.
Our approach provides an efficient intergraded platform with both evolutionary and structural insights for the rational design of pharmacophore models as well as novel modulators as the anti-T.
The identification of PLA2R as the human autoantigen and the characterization of the major PLA2R epitopes will allow the development of more relevant animal models as well as novel and more specific therapeutic approaches, including antibody inhibition therapy and immunoadsorption of circulating autoantibodies [ 65, 66].
Numerous in vitro and in vivo models, as well as novel analytical techniques for human samples, are helping to delineate the many pathways implicated in this disease, albeit at a frustratingly slow pace.
Here, we reviewed the molecular mechanisms underlying this sequence of events that ultimately leads to AL amyloidosis and also discuss current in vitro and in vivo models, as well as relevant novel therapeutic approaches.
In this chapter we present an overview on the computational aspects of bone tissue engineering, with particular emphasis on the recent mechanobiological based finite element models, as well as on novel aspects regarding the numerical characterization of the network of scaffold voids.
Our approach to ncRNA discovery is distinguished from prior work by our robust evaluation of annotation models as well as a novel procedure for false-positive estimation.
Developments over the past decade include the generation of novel models as well as pathway analysis and therapeutic targeting in classic models.
Specifically, we first focused on the best-annotated songbird species, the Zebra finch, retrieving all Zebra finch Ensembl gene models annotated as novel, duplicated, or expanded (>7,000 models, e59), and removing models Ensembl considered to have orthologs in other species (n = 5,459), as well as those mapped to chromosome Unknown (n = 1,179), which were likely to represent allelic variants.
Here, we have curated the Zebra finch Ensembl gene models annotated as novel or duplicated, as well as several previously identified novel expansions in the Zebra finch genome (Supplementary Figure Three in [ 27]), and then determined their presence or absence in 45 recently sequenced, high-coverage (30 120X) genomes spanning the avian phylogeny (phylogeny and genomes described in [ 34, 35]).
